Hong Kong Stock Midday Review | Hang Seng Index fell 0.89% in the morning session, Hang Seng Biotechnology Index rebounded 2.16%

According to Zhitong Finance APP, the Hang Seng Index fell by 0.89%, down 232 points, closing at 26,050 points; the Hang Seng Tech Index dropped by 1.91%. The Hong Kong stock market had a turnover of HKD 142.3 billion in the morning session. The Hang Seng Biotechnology Index rebounded by 2.16%. Among the index constituents, InnoCare Pharma-B (09606) rose by 10.88%; 3SBIO (01530) increased by over 10%; Innovent Biologics rose by 6.82%; Kelun-Biotech (06990) gained 5.69%. FUSEN PHARM (01652) surged nearly 74% during the session, with a morning increase of 59.42%; Enzalutamide soft capsules were approved for market launch, and Metformin and Ertugliflozin tablets are expected to be selected for national procurement. Rongchang Bio (09995) rose by 6.75%, with a 40% year-on-year increase in revenue for the first three quarters, and a significant narrowing of losses. Chunli Medical (01858) increased by over 21%, turning a profit in the third quarter with earnings of HKD 77.0619 million, as the company actively expands its international market business. New stock DEEPEXI TECH (01384) continued to soar by 18.97%, with its stock price doubling three days after listing. Ansteel (00347) fell by over 8%, with a net loss of RMB 2.04 billion for the first three quarters, a year-on-year narrowing. Zoomlion Heavy Industry (01157) rose by over 3% after earnings, with a 24.89% year-on-year increase in net profit attributable to shareholders for the first three quarters, as the company continues to expand its mining machinery business. China Everbright Bank (06818) fell by 5% after earnings, with both revenue and profit declining in the first three quarters, and fair value changes putting pressure on profits. Huahao Zhongtian Pharmaceutical-B (02563) once dropped over 37%, facing a large unlock after one year of listing. Lion Holding (02562) plummeted over 24% to a new low, planning to issue convertible bonds to raise approximately HKD 260 million for investment in gold and related products. Air China (00753) fell over 8%, with a more than 11% decline in net profit for the third quarter, planning to raise no more than RMB 20 billion through a private placement of A-shares